Thursday, March 01, 2018 3:45:53 PM
As far as sales growth goes, Brian mentioned the possibility of expanding the number of SKUs under the Saudi contracts. The company has also been making investments in the UK and recently got CovaWound products added to the Scottish Drug Tariff program in February 2018:
http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Scottish-Drug-Tariff/Amendments/Docs/2018/2018-02-SDT-AMD-v3.pdf?05:34:36
I also just found their Iranian distributor has a nice informative web presence:
http://m-s-f.ir/%D9%85%D9%82%D8%A7%D9%84%D8%A7%D8%AA-%D8%A7%D9%86%DA%AF%D9%84%DB%8C%D8%B3%DB%8C/?lang=en
It doesn't take much imagination to see there's still lots of room for growth here, it's just a matter of whether payors will be willing to pay for higher quality products.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM